Recent Company News

• 05:46 PM ET May 21, 2026
  

  Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress ($29.19, 0.00)

• 05:20 PM ET May 19, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 03:37 PM ET May 18, 2026
  

  Sanofi notes data from global ElevAATe phase 2 study of efdoralprin alfa being presented at 2026 ATS International Conference (€74.34, 0.00)

• 10:53 AM ET May 18, 2026
  

  StreetAccount Summary - Private company transactions for the week ended 16-May

• 08:33 PM ET May 15, 2026
  

  Phase 3 trial of LAG-3 inhibitor fianlimab in combination with PD-1 did not achieve primary endpoint of PFS ($698.25, 0.00)

• 09:59 AM ET May 13, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (252 total)

• 04:15 AM ET May 12, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (78 total)

• 09:44 AM ET May 11, 2026
  

  StreetAccount Summary - Private company transactions for the week ended 09-May

• 10:59 AM ET May 10, 2026
  

  MoonLake Immunotherapeutics reports positive final outcome from final pre-BLA meeting with FDA, reports Q1 EPS ($0.98) vs FactSet ($0.89) [12 est, ($1.01)-(0.79)] ($17.06, 0.00)

• 09:58 AM ET May 08, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (169 total)